MODULATION OF BCL-2 TO ENHANCE CHIMERIC ANTIGEN RECEPTOR CANCER IMMUNOTHERAPY EFFICACY Application WO-2023019165-A1 World Intellectual Property Organisation (WIPO) 16 Feb 2023
COMBINATION THERAPY OF A CELL THERAPY AND A BCL2 INHIBITOR Application WO-2022133030-A1 World Intellectual Property Organisation (WIPO) 23 Jun 2022
COMBINATION THERAPIES WITH CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELLS Application WO-2022104061-A1 World Intellectual Property Organisation (WIPO) 19 May 2022
METHODS FOR ENHANCING T CELLS USING VENETOCLAX Application WO-2021155479-A1 World Intellectual Property Organisation (WIPO) 12 Aug 2021